Carrick Therapeutics Co-Founder Wins 2018 EY Emerging Entrepreneur of the Year Award
Dr Elaine Sullivan, co-founder and CEO of Carrick Therapeutics, was last night named winner of the 2018 EY Emerging Entrepreneur of the Year TM (EOY) Award at the 21st annual awards ceremony held in Dublin.
Carrick Therapeutics was established in 2016 with the aim of building Europe’s leading oncology company. It brings together world-class cancer researchers and drug development experts, backed by some of the most eminent scientific investors.
The company, which has raised $95 million in funding, is a University College Dublin (UCD) spin-in company and is headquartered at NovaUCD, the Centre for New Ventures and Entrepreneurs.
Dr Elaine O’Sullivan, CEO, Carrick Therapeutics said, “I am delighted to have won the Emerging Entrepreneur of the Year Award. It was a privilege to take part in the EY Awards programme and the award is a great recognition of the hard work of the whole Carrick team.”
Tom Flanagan, Director of Enterprise and Commercialisation, UCD said, “I would like to take this opportunity of congratulating Dr Elaine Sullivan, CEO, Carrick Therapeutics on winning the prestigious 2018 EY Emerging Entrepreneur of the Year Award. Elaine is a highly valued member of our community of entrepreneurs who chose to spin-in her company to UCD and locate at NovaUCD and winning this Award is truly well deserved.”
He added, “I would like to wish Elaine and her team continued success as they develop first-in-class treatments to target aggressive forms of cancer.”
Joe Healy, Divisional Manager, High Potential Start-Ups, Enterprise Ireland said, “The work Elaine and her team at Carrick Therapeutics are doing is fantastic. The company are targeting new treatments for the most aggressive and resistant cancers.”
“Since being established, Carrick has made excellent progress and is now developing two clinical assets and a pre-clinical pipeline that have the potential to meet significant unmet needs for patients. The work they are doing has the potential to have a major impact on the lives of patients and transform how cancer is treated.”
Carrick Therapeutics’ lead investors are; ARCH Venture Partners and Woodford Investment Management, with participation from Cambridge Enterprise, Cambridge Innovation Capital, Evotec, GV (Google Ventures), and Lightstone Ventures.
Research partners include; Cancer Research UK, University of Oxford, University of Cambridge and Imperial College London.
Carrick has also assembled a team of internationally recognised clinicians and scientists for its scientific advisory board, including Professor William Gallagher, Director, UCD Conway Institute.
Peter Coppinger and Dan Mackey, the founders of Cork technology firm Teamwork, was named overall winner of the 2018 Entrepreneur of the Year TM (EOY) Award in addition to winning the 2018 EY International Entrepreneur of the Year TM (EOY) Award.
Teamwork creates business management applications to make teams around the world more efficient and organised. The company has 22,000 paying customers in total across 183 countries and employs more than 200 people.
Bill Wolsey, founder, Beannchor, a Belfast-based hospitality group that employs more than 750 people, was named winner of the 2018 EY Industry Entrepreneur of the Year TM (EOY) Award.
Each year a Special Award is presented to an individual who has made a significant contribution to the island of Ireland through their entrepreneurial vision, innovation and commitment to excellence. This year, the prestigious honour was awarded to Sean O’Sullivan, SOSV.
Kevin McLoughlin, Partner Lead for the EY Entrepreneur Of The Year™ Ireland said,“We are delighted to be celebrating the 21st year of the programme in Ireland. Over that time, we have seen a huge diversity in terms of the participants and the companies they are representing. Elaine Sullivan and her team at Carrick Therapeutics are doing truly life altering work. They have set out to make a real difference to people’s lives and I look forward to seeing what they can achieve. All the finalists, their families and their employees can be proud of their achievement.”
“The standard this year, as in previous years has been extremely high. On behalf of EY I would like to congratulate all of our 24 finalists, and in particular Teamwork, Beannchor Group and Carrick Therapeutics.”
The EY Entrepreneur Of The Year™ Ireland programme is designed to support, promote and connect Ireland’s entrepreneur community, and the Teamwork will now go on to represent Ireland at the World Entrepreneur of the Year Awards event in Monaco, in June 2019.
Chaired by the 2006 EY Entrepreneur Of The Year™ overall winner Anne Heraty, the judging panel includes previous EY Entrepreneur Of The Year™ (overall and category) winners; Michael Carey, Mark Roden, Evelyn O’Toole, Dr Edmond Harty, Joe Hogan, Jerry Kennelly, Brendan Mooney, Pat McDonagh and Denis O’Brien as well as Joe Healy from Enterprise Ireland and Jeremy Fitch from Invest Northern Ireland.
The programme is supported by Julius Baer International; Enterprise Ireland; Invest NI; Newstalk and The Irish Times.
ENDS
26 October 2018
For further information contact Micéal Whelan, University College Dublin, Communications Manager (Innovation), e: miceal.whelan@ucd.ie, t: + 353 1 716 3712.
Editors Notes
Operating in more than 60 countries worldwide, the EY Entrepreneur of The YearTM (EOY) programme is recognised as the most prestigious business accolade for entrepreneurs. The programme is open to entrepreneurs across all sectors and growth stages, across the island of Ireland. The awards programme is divided into three categories – Emerging, Industry and International – with 8 finalists chosen per category. www.eoy.ie
Carrick Therapeutics has an ambitious patient focused vision to serve cancer patients around the world by the introduction of ground breaking cancer therapies that will transform the way cancer is treated. www.carricktherapeutics.com
At NovaUCD, the hub for new ventures and entrepreneurs at University College Dublin, we nurture and support new high-tech and knowledge-intensive companies as part of UCD's mission. At NovaUCD we provide purpose-built, state-of-the-art incubation facilities alongside a comprehensive business support programme for client companies such as Carrick Therapeutics. NovaUCD has been funded through a unique public-private partnership that includes AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx. www.ucd.ie/novaucd